STK11 and lung carcinoma: By controlling the production of telomerase reverse transcriptase (TERT), this inhibition reduces telomerase activity and causes telomere dysfunction, providing novel insights into the function of LKB1-mediated cellular senescence in lung cancer (Liu M. et al., 2024).